company background image
6661 logo

Welgene BiotechLtd TPEX:6661 Stock Report

Last Price

NT$23.30

Market Cap

NT$543.0m

7D

0%

1Y

3.1%

Updated

22 Dec, 2024

Data

Company Financials

Welgene Biotech Co.,Ltd.

TPEX:6661 Stock Report

Market Cap: NT$543.0m

My Notes

Capture your thoughts, links and company narrative

Welgene Biotech Co.,Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Welgene BiotechLtd
Historical stock prices
Current Share PriceNT$23.30
52 Week HighNT$39.40
52 Week LowNT$22.00
Beta0.31
1 Month Change-6.80%
3 Month Change-2.51%
1 Year Change3.10%
3 Year Change-3.52%
5 Year Change-13.70%
Change since IPO-16.12%

Recent News & Updates

Recent updates

Is Welgene Biotech Co.,Ltd.'s (GTSM:6661) 4.7% Dividend Sustainable?

Mar 19
Is Welgene Biotech Co.,Ltd.'s (GTSM:6661) 4.7% Dividend Sustainable?

Are Welgene BiotechLtd's (GTSM:6661) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Feb 10
Are Welgene BiotechLtd's (GTSM:6661) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Welgene Biotech Co.,Ltd.'s (GTSM:6661) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Jan 13
Welgene Biotech Co.,Ltd.'s (GTSM:6661) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Know This Before Buying Welgene Biotech Co.,Ltd. (GTSM:6661) For Its Dividend

Dec 10
Know This Before Buying Welgene Biotech Co.,Ltd. (GTSM:6661) For Its Dividend

Shareholder Returns

6661TW Life SciencesTW Market
7D0%1.9%-2.1%
1Y3.1%-25.1%25.6%

Return vs Industry: 6661 exceeded the TW Life Sciences industry which returned -25.1% over the past year.

Return vs Market: 6661 underperformed the TW Market which returned 25.6% over the past year.

Price Volatility

Is 6661's price volatile compared to industry and market?
6661 volatility
6661 Average Weekly Movement6.3%
Life Sciences Industry Average Movement4.2%
Market Average Movement4.4%
10% most volatile stocks in TW Market7.8%
10% least volatile stocks in TW Market2.1%

Stable Share Price: 6661's share price has been volatile over the past 3 months compared to the TW market.

Volatility Over Time: 6661's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of TW stocks.

About the Company

FoundedEmployeesCEOWebsite
2003n/aYi Xing Linwww.welgene.com.tw

Welgene Biotech Co.,Ltd. provides genetic testing services. The company offers research services, including sequencing, microarray, qPCR verification, nucleic acid extraction/QC, LCM single cell experiment, and bioinformatics analysis services; and Cytoscan, an array-based comparative genomic hybridization.

Welgene Biotech Co.,Ltd. Fundamentals Summary

How do Welgene BiotechLtd's earnings and revenue compare to its market cap?
6661 fundamental statistics
Market capNT$542.99m
Earnings (TTM)-NT$1.29m
Revenue (TTM)NT$308.55m

1.8x

P/S Ratio

-419.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6661 income statement (TTM)
RevenueNT$308.55m
Cost of RevenueNT$180.92m
Gross ProfitNT$127.63m
Other ExpensesNT$128.92m
Earnings-NT$1.29m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.056
Gross Margin41.36%
Net Profit Margin-0.42%
Debt/Equity Ratio40.6%

How did 6661 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 02:23
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Welgene Biotech Co.,Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yenya KuoCapital Securities Corporation